Global Neurological Disease Model Chip Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Neurological Disease Model Chip market size was valued at US$ 56.4 million in 2024 and is forecast to a readjusted size of USD 95.3 million by 2031 with a CAGR of 7.9% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.
The neurological disease model chip market is a high-profile market segment in the biomedical field and has shown a rapid growth trend in recent years. With the deepening of neuroscience research and the continuous advancement of technology, more and more scientific research institutions and pharmaceutical companies have begun to pay attention to and invest in this field, promoting the expansion of the market scale. Neurological disease model chips are widely used in many fields such as neuroscience research, drug research and development, disease diagnosis and treatment. By simulating the structure and function of the nervous system, it can help researchers gain a deeper understanding of the pathogenesis of neurological diseases and find new treatments. In summary, the neurological disease model chip market has broad application prospects and huge market potential.
This report is a detailed and comprehensive analysis for global Neurological Disease Model Chip market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neurological Disease Model Chip market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neurological Disease Model Chip market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neurological Disease Model Chip market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neurological Disease Model Chip market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurological Disease Model Chip
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurological Disease Model Chip market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, CN Bio, TissUse, AxoSim Technologies, Nortis, Mimetas, SynVivo, Axion Biosystems, Tara Biosystems, InSphero, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Neurological Disease Model Chip market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Neuron Chip
Brain Chip
Brain Organ Chip
Market segment by Application
Pharmaceutical R&D
Neuroscience Research
Clinical Diagnosis
Major players covered
Emulate
CN Bio
TissUse
AxoSim Technologies
Nortis
Mimetas
SynVivo
Axion Biosystems
Tara Biosystems
InSphero
Hesperos
Kugelmeiers
Ascendance Biotechnology
BioIVT
BGI Genomics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurological Disease Model Chip product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurological Disease Model Chip, with price, sales quantity, revenue, and global market share of Neurological Disease Model Chip from 2020 to 2025.
Chapter 3, the Neurological Disease Model Chip competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurological Disease Model Chip breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Neurological Disease Model Chip market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurological Disease Model Chip.
Chapter 14 and 15, to describe Neurological Disease Model Chip sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.
The neurological disease model chip market is a high-profile market segment in the biomedical field and has shown a rapid growth trend in recent years. With the deepening of neuroscience research and the continuous advancement of technology, more and more scientific research institutions and pharmaceutical companies have begun to pay attention to and invest in this field, promoting the expansion of the market scale. Neurological disease model chips are widely used in many fields such as neuroscience research, drug research and development, disease diagnosis and treatment. By simulating the structure and function of the nervous system, it can help researchers gain a deeper understanding of the pathogenesis of neurological diseases and find new treatments. In summary, the neurological disease model chip market has broad application prospects and huge market potential.
This report is a detailed and comprehensive analysis for global Neurological Disease Model Chip market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neurological Disease Model Chip market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neurological Disease Model Chip market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neurological Disease Model Chip market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Neurological Disease Model Chip market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurological Disease Model Chip
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurological Disease Model Chip market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, CN Bio, TissUse, AxoSim Technologies, Nortis, Mimetas, SynVivo, Axion Biosystems, Tara Biosystems, InSphero, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Neurological Disease Model Chip market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Neuron Chip
Brain Chip
Brain Organ Chip
Market segment by Application
Pharmaceutical R&D
Neuroscience Research
Clinical Diagnosis
Major players covered
Emulate
CN Bio
TissUse
AxoSim Technologies
Nortis
Mimetas
SynVivo
Axion Biosystems
Tara Biosystems
InSphero
Hesperos
Kugelmeiers
Ascendance Biotechnology
BioIVT
BGI Genomics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurological Disease Model Chip product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurological Disease Model Chip, with price, sales quantity, revenue, and global market share of Neurological Disease Model Chip from 2020 to 2025.
Chapter 3, the Neurological Disease Model Chip competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurological Disease Model Chip breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Neurological Disease Model Chip market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurological Disease Model Chip.
Chapter 14 and 15, to describe Neurological Disease Model Chip sales channel, distributors, customers, research findings and conclusion.
Table of Contents
122 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Neurological Disease Model Chip by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
